| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.23B | 54.10B | 50.17B | 50.63B | 48.47B | 41.18B |
| Gross Profit | 19.88B | 19.29B | 16.52B | 16.17B | 16.04B | 13.77B |
| EBITDA | 5.92B | 5.74B | 4.83B | 5.72B | 6.00B | 4.19B |
| Net Income | 2.54B | 2.75B | 1.69B | 2.11B | 2.60B | 1.04B |
Balance Sheet | ||||||
| Total Assets | 64.77B | 62.37B | 56.92B | 56.12B | 54.53B | 53.17B |
| Cash, Cash Equivalents and Short-Term Investments | 10.62B | 10.73B | 8.34B | 7.05B | 7.66B | 7.96B |
| Total Debt | 13.47B | 9.90B | 9.27B | 10.43B | 11.84B | 16.49B |
| Total Liabilities | 29.17B | 25.81B | 24.10B | 25.73B | 27.21B | 30.01B |
| Stockholders Equity | 32.72B | 33.65B | 30.13B | 27.96B | 25.05B | 21.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.41B | 2.94B | 970.00M | 3.28B | 5.14B |
| Operating Cash Flow | 0.00 | 6.03B | 4.09B | 2.32B | 4.72B | 6.48B |
| Investing Cash Flow | 0.00 | -5.14B | -876.00M | -885.00M | -994.00M | -1.55B |
| Financing Cash Flow | 0.00 | -328.00M | -1.74B | -1.96B | -5.02B | -3.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥25.19B | 10.05 | ― | 3.57% | 6.99% | -0.30% | |
80 Outperform | ¥29.08B | 5.85 | ― | 4.33% | -3.45% | 30.52% | |
78 Outperform | ¥199.83B | 15.50 | ― | 1.48% | 8.80% | 33.39% | |
77 Outperform | ¥6.30B | 6.12 | ― | 1.98% | 8.43% | 2.99% | |
74 Outperform | ¥6.15B | 8.74 | ― | 3.21% | 9.92% | -27.64% | |
66 Neutral | ¥31.89B | 11.64 | ― | 0.14% | 9.78% | 40.00% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |